Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study

Published:2015-03-02 Issue:3 Volume:9 Page:e0003518
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Perry Meghan R.,Prajapati Vijay K.,Menten Joris,Raab Andrea,Feldmann Joerg,Chakraborti Dipankar,Sundar Shyam,Fairlamb Alan H.,Boelaert Marleen,Picado Albert

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference42 articles.

1. Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic;S Sundar;Clin Infect Dis,2000

2. Leishmaniasis worldwide and global estimates of its incidence;J Alvar;PLoS One,2012

3. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India;M Boelaert;Trop Med Int Health,2009

4. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis;F Chappuis;Br Med J,2006

5. Control of the Leishmaniases;Control of the Leishmaniases,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared challenges to the control of complex intracellular neglected pathogens;Frontiers in Public Health;2024-09-11

2. Mechanistic studies of adsorption and ion exchange of Si(OH)4 molecules on the surface of scorodites;Journal of Molecular Graphics and Modelling;2024-07

3. Identification of Novel Flavonoids and Ansa-Macrolides with Activities against Leishmania donovani through Natural Product Library Screening;Pathogens;2024-02-28

4. Arsenic exposure to mouse visceral leishmaniasis model through their drinking water linked to the disease exacerbation via modulation in host protective immunity: a preclinical study;Scientific Reports;2023-12-05

5. Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022);Expert Opinion on Therapeutic Patents;2023-03-04